150 related articles for article (PubMed ID: 16114791)
21. Organization and expression of basement membrane collagen IV genes and their roles in human disorders.
Sado Y; Kagawa M; Naito I; Ueki Y; Seki T; Momota R; Oohashi T; Ninomiya Y
J Biochem; 1998 May; 123(5):767-76. PubMed ID: 9562604
[TBL] [Abstract][Full Text] [Related]
22. Novel COL4A5/COL4A6 deletions and further characterization of the diffuse leiomyomatosis-Alport syndrome (DL-AS) locus define the DL critical region.
Heidet L; Cohen-Solal L; Boye E; Thorner P; Kemper MJ; David A; Larget Piet L; Zhou J; Flinter F; Zhang X; Gubler MC; Antignac C
Cytogenet Cell Genet; 1997; 78(3-4):240-6. PubMed ID: 9465897
[TBL] [Abstract][Full Text] [Related]
23. [Diffuse leiomyomatosis with genital involvement and Alport syndrome. Report of two cases].
Le Bras A; David A; Knipping M; Mensier A; Heidet L; Lopes P
J Gynecol Obstet Biol Reprod (Paris); 1998 Sep; 27(5):523-8. PubMed ID: 9791580
[TBL] [Abstract][Full Text] [Related]
24. Alport syndrome. An inherited disorder of renal, ocular, and cochlear basement membranes.
Kashtan CE
Medicine (Baltimore); 1999 Sep; 78(5):338-60. PubMed ID: 10499074
[TBL] [Abstract][Full Text] [Related]
25. [Esophageal leiomyomatosis revealing an Alport syndrome].
Abbes K; Ayadi L; Makni S; Kharrat M; Affes N; Kallel R; Gouiaa N; Ben Hmida M; Hachicha J; Beyrouti MI; Sellami Boudawara T
Rev Med Interne; 2009 Jan; 30(1):88-90. PubMed ID: 18433941
[TBL] [Abstract][Full Text] [Related]
26. MLPA and cDNA analysis improves COL4A5 mutation detection in X-linked Alport syndrome.
Hertz JM; Juncker I; Marcussen N
Clin Genet; 2008 Dec; 74(6):522-30. PubMed ID: 18616531
[TBL] [Abstract][Full Text] [Related]
27. Alport syndrome and diffuse leiomyomatosis: deletions in the 5' end of the COL4A5 collagen gene.
Antignac C; Zhou J; Sanak M; Cochat P; Roussel B; Deschênes G; Gros F; Knebelmann B; Hors-Cayla MC; Tryggvason K
Kidney Int; 1992 Nov; 42(5):1178-83. PubMed ID: 1453602
[TBL] [Abstract][Full Text] [Related]
28. [Alport syndrome: Hereditary nephropathy associated with mutations in genes coding for type IV collagen chains].
Heidet L; Gubler MC
Nephrol Ther; 2016 Dec; 12(7):544-551. PubMed ID: 27816395
[TBL] [Abstract][Full Text] [Related]
29. Functional assessment of a novel COL4A5 splice region variant and immunostaining of plucked hair follicles as an alternative method of diagnosis in X-linked Alport syndrome.
Malone AF; Funk SD; Alhamad T; Miner JH
Pediatr Nephrol; 2017 Jun; 32(6):997-1003. PubMed ID: 28013382
[TBL] [Abstract][Full Text] [Related]
30. Clinical Manifestations of Alport Syndrome-Diffuse Leiomyomatosis Patients With Contiguous Gene Deletions in
Zhou X; Wang J; Mao J; Ye Q
Front Med (Lausanne); 2021; 8():766224. PubMed ID: 34778325
[TBL] [Abstract][Full Text] [Related]
31. Alport-leiomyomatosis syndrome: an update.
García-Torres R; Orozco L
Am J Kidney Dis; 1993 Nov; 22(5):641-8. PubMed ID: 8238008
[TBL] [Abstract][Full Text] [Related]
32. Somatic mosaicism for a mutation of the COL4A5 gene is a cause of mild phenotype male Alport syndrome.
Krol RP; Nozu K; Nakanishi K; Iijima K; Takeshima Y; Fu XJ; Nozu Y; Kaito H; Kanda K; Matsuo M; Yoshikawa N
Nephrol Dial Transplant; 2008 Aug; 23(8):2525-30. PubMed ID: 18332068
[TBL] [Abstract][Full Text] [Related]
33. Genetic, Clinical, and Pathologic Backgrounds of Patients with Autosomal Dominant Alport Syndrome.
Kamiyoshi N; Nozu K; Fu XJ; Morisada N; Nozu Y; Ye MJ; Imafuku A; Miura K; Yamamura T; Minamikawa S; Shono A; Ninchoji T; Morioka I; Nakanishi K; Yoshikawa N; Kaito H; Iijima K
Clin J Am Soc Nephrol; 2016 Aug; 11(8):1441-1449. PubMed ID: 27281700
[TBL] [Abstract][Full Text] [Related]
34. [Clinical and genetic features of X-linked Alport syndrome in men positive for the collagen Ⅳ α5 chain in epidermal basement membrane].
Zhang Y; Ding J; Wang F; Zhang H; Xiao H; Yao Y; Zhong X; Guan N; Liu X; Yu L; Liu J; Yang J
Zhonghua Er Ke Za Zhi; 2016 Jan; 54(1):61-4. PubMed ID: 26791927
[TBL] [Abstract][Full Text] [Related]
35. A family case of X-linked Alport syndrome patients with a novel variant in COL4A5.
Kashiwagi Y; Suzuki S; Agata K; Morishima Y; Inagaki N; Numabe H; Kawashima H
CEN Case Rep; 2019 May; 8(2):75-78. PubMed ID: 30293132
[TBL] [Abstract][Full Text] [Related]
36. Identification of 17 mutations in ten exons in the COL4A5 collagen gene, but no mutations found in four exons in COL4A6: a study of 250 patients with hematuria and suspected of having Alport syndrome.
Heiskari N; Zhang X; Zhou J; Leinonen A; Barker D; Gregory M; Atkin CL; Netzer KO; Weber M; Reeders S; Grönhagen-Riska C; Neumann HP; Trembath R; Tryggvason K
J Am Soc Nephrol; 1996 May; 7(5):702-9. PubMed ID: 8738805
[TBL] [Abstract][Full Text] [Related]
37. Mutations in Alport syndrome associated with diffuse esophageal leiomyomatosis.
Antignac C; Heidet L
Contrib Nephrol; 1996; 117():172-82. PubMed ID: 8801045
[No Abstract] [Full Text] [Related]
38. A case with somatic and germline mosaicism in COL4A5 detected by multiplex ligation-dependent probe amplification in X-linked Alport syndrome.
Aoto Y; Kise T; Nakanishi K; Nagano C; Horinouchi T; Yamamura T; Ishiko S; Sakakibara N; Shima Y; Morisada N; Iijima K; Nozu K
CEN Case Rep; 2020 Nov; 9(4):431-436. PubMed ID: 32621070
[TBL] [Abstract][Full Text] [Related]
39. X-linked Alport syndrome associated with a synonymous p.Gly292Gly mutation alters the splicing donor site of the type IV collagen alpha chain 5 gene.
Fu XJ; Nozu K; Eguchi A; Nozu Y; Morisada N; Shono A; Taniguchi-Ikeda M; Shima Y; Nakanishi K; Vorechovsky I; Iijima K
Clin Exp Nephrol; 2016 Oct; 20(5):699-702. PubMed ID: 26581810
[TBL] [Abstract][Full Text] [Related]
40. The clinical spectrum of type IV collagen mutations.
Lemmink HH; Schröder CH; Monnens LA; Smeets HJ
Hum Mutat; 1997; 9(6):477-99. PubMed ID: 9195222
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
